Search

everythinglearnresearchcommunity

for

Search:↓

Prostate cancer cells can make their own androgens to activate the androgen receptor, and treatments like abiraterone may increase this ability, suggesting new therapies should target the entire steroid-making pathway.

Steroidogenesis inhibitors change but don't stop androgen production in prostate cancer.

Potential new drugs for treating PCOS were identified.

Estrogen affects how vitamin A is processed in mouse skin, which may impact acne treatment, hair growth, and skin defense.

Epristeride's metabolism involves key metabolites and proteins, affecting its use in doping tests.

Blocking CYP17A1 enzyme may help improve certain brain function issues related to dopamine.

Minoxidil may work for hair loss by reducing androgen sensitivity and altering hormone-related enzymes.

No link found between aromatase gene and female hair loss.

SGLT2 inhibitors may help manage PCOS symptoms effectively.

Aromatase inhibitor therapy for breast cancer increases the risk of hair loss and thinning.

Two gene variations, rs6493497 and rs7176005, may be linked to female hair loss in Chinese people.

Genetic differences within ethnic groups may affect prostate cancer treatment effectiveness.

The medications 5α-reductase inhibitors and spironolactone are generally safe for breast cancer patients on endocrine therapies and do not significantly increase breast cancer risk.

Topical patidegib gel effectively treats basal cell carcinoma in Gorlin syndrome patients without causing the side effects seen with oral treatments.

Certain drugs change freshwater snail shells to a "banana" shape.

Removing REDD1 in mice increases skin fat by making fat cells larger and more numerous.

Certain drugs that block specific enzymes can help treat prostate diseases.

Avicennia marina shows potential to treat Hepatitis C by targeting key proteins.

Modifying steroidal inhibitors shows promise for developing new cancer treatments.

New treatments for prostate cancer and BPH show promise, including novel compounds that target hormone synthesis and response.

Steroid-producing capabilities in certain cancers may contribute to treatment resistance.

MitoQ helps protect hair cells from damage in hair loss by boosting a protective enzyme.

Combined finasteride and anastrozole therapy effectively treats BPH, influenced by hormone imbalances and genetics.

A male with aromatase deficiency improved bone health with estradiol treatment.

MitoQ may help treat hair loss by boosting hair growth pathways.

Different substances that activate or block the androgen receptor can affect male development and treat conditions like prostate cancer.

The review suggests that while many AKR1C3 inhibitors show promise for treating certain cancers, more research is needed to confirm their effectiveness in humans.

The conclusion is that while oral contraceptive pills are effective for PCOS-related high androgen levels, new treatments with fewer side effects are needed.

Early diagnosis and personalized treatment for PCOS are crucial, especially for young women in West Bengal, India.

Young women in West Bengal, India, with PCOS often have estrogen resistance, leptin receptor issues, folate deficiency, T2DM, and acanthosis, commonly linked to obesity.